Mount Sinai gets rare FDA approval to test for immunity to Covid-19.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): LAMANTIA, JONATHAN (AUTHOR)
  • Source:
    Crain's New York Business. 4/27/2020, Vol. 36 Issue 15, p17-17. 1p.
  • Additional Information
    • Subject Terms:
      UNITED States. Food & Drug Administration; COVID-19; IMMUNITY; MEDICAL personnel
    • Subject Terms:
      SINAI, Mount (Egypt)
    • Abstract:
      The Mount Sinai Laboratory is one of only a handful of labs to receive emergency authorization from the Food and Drug Administration to test whether patients have the antibodies to fight off the virus that causes Covid-19. One of few Mount Sinai joins a short list of diagnostic companies that have been granted emergency authorization by the FDA. [Extracted from the article]
    • Abstract:
      Copyright of Crain's New York Business is the property of Crain Communications Inc. (MI) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)